- Filed
- Mar 25, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Mar 19, 2021 | 29.42M sh |
| Shares Diluted | FY 2020 · Dec 31, 2019 | 29.43M sh |
| Capex | FY 2020 · Dec 31, 2019 | $660.01K |
| Operating Cash Flow restated | FY 2020 · Dec 31, 2019 | $5.41M |
| Long Term Debt restated | FY 2020 · Dec 31, 2019 | $1.18M |
| Short Term Debt | FY 2020 · Dec 31, 2019 | $8.1M |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $12.62M |
| Stockholders Equity | FY 2020 · Dec 31, 2019 | $26.24M |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $37.4M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $43.49M |
| Current Assets | FY 2020 · Dec 31, 2019 | $75.99M |
| Total Assets | FY 2020 · Dec 31, 2019 | $89.24M |
| Eps Diluted | FY 2020 · Dec 31, 2019 | $0.10 |
| Eps Basic | FY 2020 · Dec 31, 2019 | $0.10 |
| Sga Expense | FY 2020 · Dec 31, 2019 | $20.21M |
| Net Income | FY 2020 · Dec 31, 2019 | $3.06M |
| Operating Income | FY 2020 · Dec 31, 2019 | $7.65M |
| Gross Profit | FY 2020 · Dec 31, 2019 | $30.58M |
| Revenue | FY 2020 · Dec 31, 2019 | $95.92M |